Affimed

Affimed is a biopharmaceutical company dedicated to the discovery and development of recombinant antibody therapies for the treatment of cancer and other diseases. It provides TandAbs, a type of tetravalent antibody that targets tumor cells. The company also offers solutions for treating non-Hodgkin lymphoma, Hodgkin's disease, thrombosis and autoimmunity, leukemia, myeloma, solid tumors, metastasis, non-cancer indications, allergies, and asthma. Affimed was founded in 2000 and is headquartered in Heidelberg, Germany.